{"id":"W1981378897","doi":"10.1111/dme.12303","title":"Comparison of insulin degludec with insulin glargine in insulin‐naive subjects with Type 2 diabetes: a 2‐year randomized, treat‐to‐target trial","year":2013,"lang":"en","type":"article","venue":"Diabetic Medicine","topic":"Diabetes Management and Research","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"Merck Sharp and Dohme; Genentech; Novo Nordisk; Daiichi-Sankyo; Sanofi; Halozyme; Amarin Corporation; Gilead Sciences; MannKind Corporation; GlaxoSmithKline; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Amylin Pharmaceuticals; Pfizer","keywords":"Medicine; Insulin degludec; Insulin glargine; Insulin; Type 2 diabetes; Diabetes mellitus; Randomized controlled trial; Internal medicine; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001669424,0.0005511714,0.003004413,0.001169121,0.00006124957,0.00003003958,0.0003698346,0.0001964722,0.001177589],"category_scores_gemma":[0.00184602,0.0003207566,0.0001187326,0.002336649,0.0006958927,0.0001496015,0.0001291849,0.0006412319,0.0002305928],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000115449,"about_ca_system_score_gemma":0.0002617121,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002279614,"about_ca_topic_score_gemma":0.0000401902,"domain_scores_codex":[0.995265,0.0003965281,0.001232089,0.0007066139,0.001402403,0.0009973409],"domain_scores_gemma":[0.996716,0.0008544112,0.0003577906,0.0007975349,0.0006532767,0.0006209388],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6628177,0.004667796,0.2857842,0.002181561,0.001439547,0.0001829282,0.006257444,0.0002132647,0.003341199,0.0004060905,0.007993806,0.02471457],"study_design_scores_gemma":[0.9305628,0.01872895,0.03595393,0.003175287,0.0007375545,0.000002264863,0.00135397,0.003243363,0.003705475,0.0002820331,0.001670341,0.0005840549],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9760481,0.002645237,0.0001315889,0.003958415,0.0002194338,0.006990086,0.000005256589,0.00008352689,0.009918352],"genre_scores_gemma":[0.994527,0.0001640586,0.002092175,0.0006487737,0.0003997851,0.0006193721,0.0001560626,0.0000938095,0.001298997],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2677451,"threshold_uncertainty_score":0.9999244,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02355465107565475,"score_gpt":0.305690302390848,"score_spread":0.2821356513151933,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}